JP Patent

JP6630229B2 — レベチラセタム含有医薬組成物及びその製造方法

Assigned to エルメッド株式会社 · Expires 2020-01-15 · 6y expired

What this patent protects

Patent listed against Keppra.

Drugs covered by this patent

Patent Metadata

Patent number
JP6630229B2
Jurisdiction
JP
Classification
—
Expires
2020-01-15
Drug substance claim
No
Drug product claim
No
Assignee
エルメッド株式会社
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.